HBX-interacting protein (Hbxip) enhances cisplatin resistance in liver cancer cells by upregulating Wtap and its m6A modification of poly (Adp-ribose) polymerase (Parp1)166. The gene discussed is LAMTOR5; the disease is liver cancer.